|
MPPG Report 13.a - AAPM medical physics practice guideline 13.a: HDR brachytherapy, part B (2025) Category: MPPG Report The goal of this report is to assist the clinical medical physicist in assuring that key quality standards and practice considerations are met to ensure safe, reliable, and reproducible high dose rate (HDR) brachytherapy (BT) treatment. This guideline has been developed to provide appropriate minimum standards for such services. The secondary goal is to provide recommendations to the regulatory community from the experts to guide the adoption of regulations in the future. This MPPG is limited to iridium-192-based HDR brachytherapy and will not discuss electronic, low-dose rate, pulsed dose rate brachytherapy, or any alternative radionuclide. Journal of Applied Clinical Medical Physics https://doi.org/10.1002/acm2.70118 Altmetrics for this report Subcommittee on Practice Guidelines (SPG) Susan L. Richardson, Arjit K. Baghwala, Gil’ad N. Cohen, Claire Dempsey, Bruce Libby, Christopher S. Melhus, Robin A. Miller, Daniel J. Scanderbeg, Samantha J. Simiele |
DISCLAIMER